Patents by Inventor James Huizenga

James Huizenga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220346741
    Abstract: A method for determining a patient radiation and diagnostic study score associated with past diagnostic radiologic tests. In light of the obvious benefits of diagnostic radiology, the risks inherent in its use are often overlooked. Ionizing radiation, which is a component of much, but not all, diagnostic radiology, carries with it a small risk of inducing cancer every time it is used. The present method for determining a patient radiation and diagnostic study score provides right time, right place, and right format radiology information to assist providers in their medical decision-making. With greater awareness of recent study history, and individually contextualized risk and benefit considerations, providers are more likely to decrease their overall usage of diagnostic radiology and better counsel their patients on future risk.
    Type: Application
    Filed: July 1, 2022
    Publication date: November 3, 2022
    Inventors: James Huizenga, Brian C. Breneman, Kathleen Huizenga
  • Patent number: 11375971
    Abstract: A method for determining a patient radiation and diagnostic study score associated with past diagnostic radiologic tests. In light of the obvious benefits of diagnostic radiology, the risks inherent in its use are often overlooked. Ionizing radiation, which is a component of much, but not all, diagnostic radiology, carries with it a small risk of inducing cancer every time it is used. This additional risk, known as “Lifetime Attributable Risk,” is layered on top of an individual's lifetime base risk of invasive cancer. The present method for determining a patient radiation and diagnostic study score provides right time, right place, and right format radiology information to assist providers in their medical decision-making. With greater awareness of recent study history, and individually contextualized risk and benefit considerations, providers are more likely to decrease their overall usage of diagnostic radiology and better counsel their patients on future risk.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: July 5, 2022
    Assignee: CLINICENTRIC, LLC
    Inventors: James Huizenga, Brian C. Breneman, Kathleen Huizenga
  • Publication number: 20180263589
    Abstract: A method for determining a patient radiation and diagnostic study score associated with past diagnostic radiologic tests. In light of the obvious benefits of diagnostic radiology, the risks inherent in its use are often overlooked. Ionizing radiation, which is a component of much, but not all, diagnostic radiology, carries with it a small risk of inducing cancer every time it is used. This additional risk, known as “Lifetime Attributable Risk,” is layered on top of an individual's lifetime base risk of invasive cancer. The present method for determining a patient radiation and diagnostic study score provides right time, right place, and right format radiology information to assist providers in their medical decision-making. With greater awareness of recent study history, and individually contextualized risk and benefit considerations, providers are more likely to decrease their overall usage of diagnostic radiology and better counsel their patients on future risk.
    Type: Application
    Filed: May 21, 2018
    Publication date: September 20, 2018
    Inventors: James Huizenga, Brian C. Breneman, Kathleen Huizenga
  • Patent number: 9974512
    Abstract: A method for determining a patient radiation and diagnostic study score associated with past diagnostic radiologic tests. In light of the obvious benefits of diagnostic radiology, the risks inherent in its use are often overlooked. Ionizing radiation, which is a component of much, but not all, diagnostic radiology, carries with it a small risk of inducing cancer every time it is used. This additional risk, known as “Lifetime Attributable Risk,” is layered on top of an individual's lifetime base risk of invasive cancer. The present method for determining a patient radiation and diagnostic study score provides right time, right place, and right format radiology information to assist providers in their medical decision-making. With greater awareness of recent study history, and individually contextualized risk and benefit considerations, providers are more likely to decrease their overall usage of diagnostic radiology and better counsel their patients on future risk.
    Type: Grant
    Filed: March 9, 2015
    Date of Patent: May 22, 2018
    Assignee: CONVERGENCE MEDICAL, LLC
    Inventors: James Huizenga, Brian C. Breneman, Kathleen Huizenga
  • Publication number: 20150347706
    Abstract: A method, system, and computer program product determines a controlled substance use indicator to enable a physician, or other prescriber, to quickly review a numerical score that reflects a patient's past drug use and is indicative of proper, or improper, future drug use. This score analyzes many aspects of a patient's past activities to determine multiple individual indicator values that may be selectively weighted to create a final controlled substance use indicator. Such individual indicator values may include: a usage related indicator factoring in the patient's past drug use, particularly the type of controlled substances used; an instruction related indicator that may consider the patient's past use of prescribers, quantity of prescriptions, or the number of open prescriptions from different prescribers; a dispensing related indicator that examines a patient's use of pharmacies in filling prescriptions; or even an auxiliary indicator that may reflect the patient's number of active prescriptions.
    Type: Application
    Filed: August 11, 2015
    Publication date: December 3, 2015
    Inventor: James Huizenga
  • Publication number: 20150317443
    Abstract: A method for determining a patient radiation and diagnostic study score associated with past diagnostic radiologic tests. In light of the obvious benefits of diagnostic radiology, the risks inherent in its use are often overlooked. Ionizing radiation, which is a component of much, but not all, diagnostic radiology, carries with it a small risk of inducing cancer every time it is used. This additional risk, known as “Lifetime Attributable Risk,” is layered on top of an individual's lifetime base risk of invasive cancer. The present method for determining a patient radiation and diagnostic study score provides right time, right place, and right format radiology information to assist providers in their medical decision-making. With greater awareness of recent study history, and individually contextualized risk and benefit considerations, providers are more likely to decrease their overall usage of diagnostic radiology and better counsel their patients on future risk.
    Type: Application
    Filed: March 9, 2015
    Publication date: November 5, 2015
    Inventors: James Huizenga, Brian C. Breneman, Kathleen Huizenga
  • Publication number: 20140172464
    Abstract: A method, system, and computer program product for determining a controlled substance use indicator to enable a physician, or other prescriber, to quickly review a numerical score that reflects a patient's past drug use and is indicative of proper, or improper, future drug use. This score analyzes many aspects of a patient's past activities to determine multiple individual indicator values that may be selectively weighted to create a final controlled substance use indicator. Such individual indicator values may include a usage related indicator factoring in the patient's past drug use, particularly the type of controlled substances used; an instruction related indicator that may consider the patient's past use of prescribers, quantity of prescriptions, or the number of open prescriptions from different prescribers; a dispensing related indicator that examines a patient's use of pharmacies, in filling prescriptions; or even an auxiliary indicator that may reflect the patient's number of active prescriptions.
    Type: Application
    Filed: February 24, 2014
    Publication date: June 19, 2014
    Applicant: NATIONAL ASSOC. OF BOARDS OF PHARMACY
    Inventor: James Huizenga
  • Patent number: 8688477
    Abstract: A method, system, and computer program product for determining a narcotics use indicator to enable a physician, or other prescriber, to quickly review a numerical score that reflects a patient's past drug use and is indicative of proper, or improper, future drug use. This score analyzes many aspects of a patient's past activities to determine multiple individual indicator values that may be selectively weighted to create a final narcotics use indicator. Such individual indicator values may include a usage related indicator factoring in the patient's past drug use, particularly the type of narcotics and controlled substances used; an instruction related indicator that may consider the patient's past use of prescribers, quantity of prescriptions, or the number of open prescriptions from different prescribers; a dispensing related indicator that examines a patient's use of pharmacies, in filling prescriptions; or even an auxiliary indicator that may reflect the patient's number of active prescriptions.
    Type: Grant
    Filed: September 16, 2011
    Date of Patent: April 1, 2014
    Assignee: National Assoc. of Boards of Pharmacy
    Inventor: James Huizenga